Diabetic Retinopathy (DR)
What Is Diabetic Retinopathy?
Diabetic retinopathy is a condition in which chronically elevated blood sugar damages the tiny blood vessels that nourish the retina. Understanding how and why this damage happens is the first step toward protecting your sight.
When blood sugar remains high over months or years, the walls of retinal capillaries weaken and begin to leak fluid, blood, or fatty deposits called hard exudates into the surrounding retinal tissue. In some patients the vessels close entirely, starving areas of the retina of oxygen. The retina responds to this oxygen deprivation by triggering the growth of fragile new blood vessels, a process called neovascularization, that can bleed and scar inside the eye.
Anyone with type 1, type 2, or gestational diabetes can develop diabetic retinopathy. Risk increases with longer diabetes duration, poorly controlled blood sugar, high blood pressure, and elevated cholesterol. Pregnancy, kidney disease, and tobacco use are additional factors that can accelerate retinal damage. Because the condition can develop without warning signs, routine diabetic eye screenings are critical for every patient living with diabetes.
How Diabetes Damages the Retina
The retina requires a steady supply of oxygen and nutrients delivered through an intricate network of microscopic blood vessels. Diabetes disrupts this network through several interconnected mechanisms.
Elevated blood glucose damages the endothelial cells that line retinal capillaries, weakening the blood-retinal barrier. Once this barrier breaks down, plasma, lipids, and blood components leak into the retinal layers. When this leakage affects the macula, the central area responsible for sharp reading and driving vision, it causes a complication known as diabetic macular edema. Macular edema can develop at any stage of diabetic retinopathy and is one of the most common reasons patients notice blurred or distorted vision.
As damaged capillaries swell shut, patches of the retina lose their blood supply, a state called ischemia. Ischemic retina releases chemical signals, particularly vascular endothelial growth factor (VEGF), that attempt to restore circulation by stimulating new vessel growth. Unfortunately these new vessels are structurally weak and prone to bleeding, creating a cycle of damage that can lead to severe vision loss if untreated.
Abnormal new blood vessels may grow along the retinal surface or extend into the vitreous, the gel-like substance filling the eye. These fragile vessels can rupture, releasing blood into the vitreous cavity and causing sudden floaters or profound vision loss. Repeated bleeding episodes can lead to scar tissue that pulls on the retina, potentially causing a tractional retinal detachment that requires surgical intervention.
Stages of Diabetic Retinopathy
Diabetic retinopathy progresses through clearly defined stages, each reflecting increasing severity of retinal vascular damage. Knowing your stage helps our retina specialists tailor the right monitoring and treatment plan for you.
In this earliest stage, small balloon-like swellings called microaneurysms form in the walls of retinal blood vessels. Most patients have no symptoms at this point, and the condition is typically discovered during a dilated eye exam. Treatment usually involves close monitoring and optimizing blood sugar, blood pressure, and cholesterol levels.
As the disease advances, additional microaneurysms appear along with dot-and-blot hemorrhages and hard exudates. Some retinal blood vessels begin to swell and lose their ability to transport blood efficiently. Vision may remain stable, but the risk of progression increases, making consistent follow-up essential.
At this stage, a significant number of blood vessels are blocked, depriving large areas of the retina of adequate blood flow. The retina sends distress signals that can trigger the growth of abnormal new vessels. The four-two-one rule is a clinical guideline used to classify severe NPDR: hemorrhages in all four retinal quadrants, venous beading in two or more quadrants, or prominent intraretinal microvascular abnormalities in one or more quadrants. Patients at this stage may need more frequent visits and proactive treatment to prevent progression.
Proliferative diabetic retinopathy is the most advanced stage, characterized by the growth of new, abnormal blood vessels on the retina or optic disc. These vessels are fragile and bleed easily, leading to vitreous hemorrhage, scar tissue formation, and tractional retinal detachment. Prompt treatment with anti-VEGF injections, laser photocoagulation, or vitrectomy surgery is often necessary to stabilize vision. You can learn more about the advanced form of this condition on our proliferative diabetic retinopathy page.
Symptoms of Diabetic Retinopathy
One of the most challenging aspects of diabetic retinopathy is that it often causes no noticeable symptoms in its early stages. By the time vision changes appear, significant retinal damage may already be present.
In mild to moderate stages, most patients see normally and feel no discomfort. Some may notice subtle fluctuations in vision that come and go with blood sugar changes. These fluctuations are caused by temporary swelling of the lens inside the eye and may not directly reflect retinal damage, but they should prompt an evaluation by an eye care professional.
As diabetic retinopathy progresses, patients may experience the following:
- Blurred or fluctuating vision that does not improve with new glasses
- Dark spots, streaks, or floaters drifting across the field of vision
- Difficulty seeing at night or in low-light environments
- A dark or empty area in the center of vision, suggesting macular involvement
- Sudden, painless loss of vision, which may indicate vitreous hemorrhage or retinal detachment
A sudden shower of new floaters, flashes of light, or a curtain-like shadow over part of your vision are warning signs that require urgent evaluation. These symptoms may indicate a vitreous hemorrhage or retinal detachment, both of which need prompt treatment to give you the best chance of preserving vision. If you experience any of these changes, contact our office right away rather than waiting for your next scheduled appointment.
Frequently Asked Questions
Diagnosis begins with a comprehensive dilated eye exam, during which our retina specialists examine the retina for microaneurysms, hemorrhages, exudates, and abnormal blood vessel growth. We also use optical coherence tomography (OCT) to measure retinal thickness and detect macular edema, along with fluorescein angiography to map blood flow and identify areas of leakage or vessel closure. These imaging tools allow us to determine the exact stage of disease and develop an individualized treatment plan.
Treatment depends on the stage and severity. Early nonproliferative disease is managed with careful monitoring and systemic control of blood sugar, blood pressure, and cholesterol. For more advanced disease or diabetic macular edema, anti-VEGF injections deliver medication directly into the eye to reduce leakage and prevent new vessel growth. Laser photocoagulation, including panretinal photocoagulation (PRP) for proliferative disease, remains an important tool. In cases complicated by vitreous hemorrhage or tractional retinal detachment, vitrectomy surgery may be recommended to restore clarity and stabilize the retina.
Early-stage damage, particularly mild nonproliferative changes, can sometimes stabilize or partially improve with tight blood sugar control. However, more advanced retinal damage, including scar tissue and significant vessel loss, is generally not reversible. Treatment focuses on slowing progression, preventing further vision loss, and, where possible, improving vision through reduction of macular edema. This is one of the strongest reasons to prioritize early detection through regular exams.
Blood sugar management is the single most influential factor in diabetic retinopathy outcomes. Landmark studies have shown that maintaining hemoglobin A1C levels near or below 7% can reduce the risk of developing retinopathy by up to 76% and slow its progression significantly. It is important to note that very rapid improvements in blood sugar can temporarily worsen retinopathy in some patients, so changes in diabetes management should be made gradually and in coordination with your medical team.
Patients with type 1 diabetes should have their first dilated retinal exam within five years of diagnosis, while patients with type 2 diabetes should be examined at the time of diagnosis since retinopathy may already be present. After the initial exam, most patients benefit from annual screenings. If diabetic retinopathy is already present, our retina specialists may recommend exams every three to six months depending on the stage and whether treatment is underway.
Nonproliferative diabetic retinopathy (NPDR) involves damage to existing blood vessels, including microaneurysms, hemorrhages, and fluid leakage, but no growth of new abnormal vessels. Proliferative diabetic retinopathy (PDR) occurs when oxygen-deprived retinal tissue triggers neovascularization, the formation of fragile new blood vessels that can bleed into the vitreous and cause retinal detachment. The transition from NPDR to PDR marks a critical escalation in risk, which is why close monitoring at the severe NPDR stage is so important.
What our Patients say
4.8
Reviews
(3547)